In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes

Ann Intern Med. 2024 Jan;177(1):JC7. doi: 10.7326/J23-0108. Epub 2024 Jan 2.

Abstract

Sommer I, Ledinger D, Thaler K, et al. Outpatient treatment of confirmed COVID-19: a living, rapid evidence review for the American College of Physicians (version 2). Ann Intern Med. 2023;176:1377-1385. 37722115.

Publication types

  • Review
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment
  • COVID-19*
  • Cytidine* / analogs & derivatives
  • Humans
  • Hydroxylamines*
  • Lactams*
  • Leucine*
  • Nitriles*
  • Outpatients*
  • Proline*
  • Ritonavir / therapeutic use
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Cytidine
  • Hydroxylamines
  • Lactams
  • Leucine
  • molnupiravir
  • nirmatrelvir
  • Nitriles
  • Proline
  • Ritonavir

Supplementary concepts

  • SARS-CoV-2 variants